Story perspectives

Trump Launches Probe into Prescription Drug Pricing Disparities

10/23/2025

50 8

Summary

Story summary

U.S. President Donald Trump will launch a Section 301 investigation into prescription drug prices, aiming to raise foreign prices to U.S. levels.
The probe could trigger tariffs on pharmaceutical products under the Trade Act of 1974.
Negotiations with drugmakers continue to align U.S. prices with those in other countries.
Some firms have lowered prices under the most-favored nation policy, but tariff enforcement remains uncertain.
Drug companies generally back Section 301 tariffs to address perceived unfair pricing internationally.

1 of 1

Story summary

U.S. President Donald Trump will launch a Section 301 investigation into prescription drug prices, aiming to raise foreign prices to U.S. levels.
The probe could trigger tariffs on pharmaceutical products under the Trade Act of 1974.
Negotiations with drugmakers continue to align U.S. prices with those in other countries.
Some firms have lowered prices under the most-favored nation policy, but tariff enforcement remains uncertain.
Drug companies generally back Section 301 tariffs to address perceived unfair pricing internationally.